ADIPOQ and Insulin resistance: This threshold may represent a critical point for clinical intervention, particularly given the concomitant suppression of anti-inflammatory adipokines like adiponectin, which exacerbates insulin resistance and further adipose accumulation (Berg and Scherer, 2005; Ghigliotti et al., 2014).